Gylden Pharma Limited
PrivateLast Round
Grant
Nov 17, 2023
Total Funding Raised
$14.53M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gylden Pharma Limited is a clinical-stage biotechnology company that develops synthetic T cell-priming vaccines and immunotherapies for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gylden Pharma Limited Comparables
Compare Gylden Pharma Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verndari, Inc. | 81% | |
| Uvax Bio, LLC | 79% | |
| Micron Biomedical | 77% | |
Gylden Pharma Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 17, 2023 | ||||
| VC Round | Jun 20, 2023 | ||||
| Grant | Feb 22, 2022 | ||||
| VC Round | Nov 18, 2020 | ||||
| Series A | Jan 9, 2020 | ||||
Grant | Apr 5, 2017 |
Key People
Founding team and executive leadership
Gylden Pharma Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DHSC | Grant |
| Innovate UK | Grant |
| Vickers Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 195% MoM.
- Jun 20, 2023
Molecular Biology Institute of Paraná participated in the round.
Gylden Pharma Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gylden Pharma Limited's valuation, stock price, and market status.